Cargando…

The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis

THE AIM: To investigate the role of Sirtuin 1 (SIRT1) level and SIRT1 (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS). METHODS: 79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubiliute, Aleksandra, Gedvilaite, Greta, Vilkeviciute, Alvita, Kriauciuniene, Loresa, Bruzaite, Akvile, Zaliuniene, Dalia, Liutkeviciene, Rasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031967/
https://www.ncbi.nlm.nih.gov/pubmed/36949521
http://dx.doi.org/10.1186/s13023-023-02665-x
_version_ 1784910701780795392
author Kubiliute, Aleksandra
Gedvilaite, Greta
Vilkeviciute, Alvita
Kriauciuniene, Loresa
Bruzaite, Akvile
Zaliuniene, Dalia
Liutkeviciene, Rasa
author_facet Kubiliute, Aleksandra
Gedvilaite, Greta
Vilkeviciute, Alvita
Kriauciuniene, Loresa
Bruzaite, Akvile
Zaliuniene, Dalia
Liutkeviciene, Rasa
author_sort Kubiliute, Aleksandra
collection PubMed
description THE AIM: To investigate the role of Sirtuin 1 (SIRT1) level and SIRT1 (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS). METHODS: 79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into 2 subgroups: patients with MS (n = 30) and patients without MS (n = 43). 6 ON patients did not have sufficient data for MS diagnosis and were excluded from the subgroup analysis. DNA was extracted from peripheral blood leukocytes and genotyped by real-time polymerase chain reaction. Results were analysed using the program "IBM SPSS Statistics 27.0". RESULTS: We discovered that SIRT1 rs3758391 was associated with a twofold increased odds of developing ON under the codominant (p = 0.007), dominant (p = 0.011), and over-dominant (p = 0.008) models. Also, it was associated with a threefold increased odds ofON with MS development under the dominant (p = 0.010), twofold increased odds under the over-dominant (p = 0.032) models and a 1.2-fold increased odds of ON with MS development (p = 0.015) under the additive model. We also discovered that the SIRT1 rs7895833 was significantly associated with a 2.5-fold increased odds of ON development under the codominant (p = 0.001), dominant (p = 0.006), and over-dominant (p < 0.001) models, and a fourfold increased odds of ON with MS development under the codominant (p < 0.001), dominant (p = 0.001), over-dominant (p < 0.001) models and with a twofold increased odds of ON with MS development (p = 0.013) under the additive genetic model. There was no association between SIRT1 levels and ON with/without MS development. CONCLUSIONS: SIRT1 rs3758391 and rs7895833 polymorphisms are associated with ON and ON with MS development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02665-x.
format Online
Article
Text
id pubmed-10031967
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100319672023-03-23 The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis Kubiliute, Aleksandra Gedvilaite, Greta Vilkeviciute, Alvita Kriauciuniene, Loresa Bruzaite, Akvile Zaliuniene, Dalia Liutkeviciene, Rasa Orphanet J Rare Dis Research THE AIM: To investigate the role of Sirtuin 1 (SIRT1) level and SIRT1 (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS). METHODS: 79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into 2 subgroups: patients with MS (n = 30) and patients without MS (n = 43). 6 ON patients did not have sufficient data for MS diagnosis and were excluded from the subgroup analysis. DNA was extracted from peripheral blood leukocytes and genotyped by real-time polymerase chain reaction. Results were analysed using the program "IBM SPSS Statistics 27.0". RESULTS: We discovered that SIRT1 rs3758391 was associated with a twofold increased odds of developing ON under the codominant (p = 0.007), dominant (p = 0.011), and over-dominant (p = 0.008) models. Also, it was associated with a threefold increased odds ofON with MS development under the dominant (p = 0.010), twofold increased odds under the over-dominant (p = 0.032) models and a 1.2-fold increased odds of ON with MS development (p = 0.015) under the additive model. We also discovered that the SIRT1 rs7895833 was significantly associated with a 2.5-fold increased odds of ON development under the codominant (p = 0.001), dominant (p = 0.006), and over-dominant (p < 0.001) models, and a fourfold increased odds of ON with MS development under the codominant (p < 0.001), dominant (p = 0.001), over-dominant (p < 0.001) models and with a twofold increased odds of ON with MS development (p = 0.013) under the additive genetic model. There was no association between SIRT1 levels and ON with/without MS development. CONCLUSIONS: SIRT1 rs3758391 and rs7895833 polymorphisms are associated with ON and ON with MS development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02665-x. BioMed Central 2023-03-22 /pmc/articles/PMC10031967/ /pubmed/36949521 http://dx.doi.org/10.1186/s13023-023-02665-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kubiliute, Aleksandra
Gedvilaite, Greta
Vilkeviciute, Alvita
Kriauciuniene, Loresa
Bruzaite, Akvile
Zaliuniene, Dalia
Liutkeviciene, Rasa
The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis
title The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis
title_full The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis
title_fullStr The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis
title_full_unstemmed The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis
title_short The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis
title_sort role of sirt1 level and sirt1 gene polymorphisms in optic neuritis patients with multiple sclerosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031967/
https://www.ncbi.nlm.nih.gov/pubmed/36949521
http://dx.doi.org/10.1186/s13023-023-02665-x
work_keys_str_mv AT kubiliutealeksandra theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT gedvilaitegreta theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT vilkeviciutealvita theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT kriauciunieneloresa theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT bruzaiteakvile theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT zaliunienedalia theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT liutkevicienerasa theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT kubiliutealeksandra roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT gedvilaitegreta roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT vilkeviciutealvita roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT kriauciunieneloresa roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT bruzaiteakvile roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT zaliunienedalia roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis
AT liutkevicienerasa roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis